Compare HTHT & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HTHT | ZBH |
|---|---|---|
| Founded | 2005 | 1927 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.8B | 17.6B |
| IPO Year | 2010 | N/A |
| Metric | HTHT | ZBH |
|---|---|---|
| Price | $53.33 | $95.28 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 19 |
| Target Price | $47.00 | ★ $105.39 |
| AVG Volume (30 Days) | 1.6M | ★ 2.5M |
| Earning Date | 03-19-2026 | 02-10-2026 |
| Dividend Yield | ★ 3.35% | 1.00% |
| EPS Growth | ★ 7.24 | N/A |
| EPS | 1.76 | ★ 3.55 |
| Revenue | $3,484,239,807.00 | ★ $8,231,500,000.00 |
| Revenue This Year | $7.12 | $5.67 |
| Revenue Next Year | $6.64 | $4.13 |
| P/E Ratio | $30.28 | ★ $26.93 |
| Revenue Growth | 5.77 | ★ 7.20 |
| 52 Week Low | $30.20 | $84.59 |
| 52 Week High | $53.47 | $114.44 |
| Indicator | HTHT | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 65.12 | 68.85 |
| Support Level | $50.21 | $90.22 |
| Resistance Level | $53.47 | $90.09 |
| Average True Range (ATR) | 1.77 | 2.52 |
| MACD | 0.41 | 1.12 |
| Stochastic Oscillator | 76.47 | 85.04 |
H World Group Ltd is a multi-brand hotel group in China with international operations. It operates in the leased, managed, and franchised models. The company has two operating segments: legacy Huazhu and legacy DH. Its brand and product offering includes Economy hotel brands: HanTing Hotel, Ni Hao Hotel, Hi Inn, Elan Hotel, Zleep Hotels, and Ibis Hotel, Midscale hotel brands: JI Hotel, Orange Hotel, Starway Hotel and Ibis Styles Hotel, Upper midscale hotel brands: Crystal Orange Hotel, IntercityHotel, Manxin Hotel, Mercure Hotel, Madison Hotel, Novotel Hotel, CitiGO Hotel and MAXX by Steigenberger, Upscale hotel brands: Joya Hotel, Blossom House, Steigenberger Hotels & Resorts, Jaz in the City, and Grand Mercure; and Luxury hotel brand: Steigenberger Icon and Song Hotels.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.